Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27477335 | 0.75 | MEN1 (0.39) | MEN1KMT2A | |
| SCHEMBL29669513 | 0.67 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL25594688 | 0.65 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL991455 | 0.63 | — | — | |
| SCHEMBL19901608 | 0.61 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL5822510 | 0.59 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL9579552 | 0.59 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL27929996 | 0.57 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL11122660 | 0.57 | MAPK1 (0.38) | MEN1KMT2A | |
| SCHEMBL7529812 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376515-A1 | Synthesis of purine nucleosides | Pharmasset, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| EP-2313422-A2 | NUCLEOSIDE CYCLICPHOSPHATES | Pharmasset, Inc. (US) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010075554-A1 | SYNTHESIS OF PURINE NUCLEOSIDES | PHARMASSET, INC. (US) | 2010-07-01 | — | — | WO | disclosed |
| WO-2009152095-A2 | NUCLEOSIDE CYCLICPHOSPHATES | PHARMASSET, INC. (US) | 2009-12-17 | — | — | WO | disclosed |
| US-5969135-A | COMPOUNDS FOR USE AS ANTISENSE CONTROL OF GENE EXPRESSION AND HYBRIDIZATION | ICN PHARMACEUTICALS, INC. (US) | 1999-10-19 | — | — | US | disclosed |
| EP-0789707-A4 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1999-02-24 | — | — | EP | disclosed |
| EP-0789707-A1 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1997-08-20 | — | — | EP | disclosed |
| EP-0416817-B1 | Amplification processes | ZENECA LTD (GB) | 1996-10-16 | — | — | EP | disclosed |
| US-5525494-A | Amplification processes | ZENECA LIMITED (GB) | 1996-06-11 | — | — | US | disclosed |
| WO-1996014330-A1 | AMINO ACID NUCLEIC ACIDS | ICNPHARMACEUTICALS (US) | 1996-05-17 | — | — | WO | disclosed |
| EP-0416817-A2 | Amplification processes | ZENECA LIMITED (GB) | 1991-03-13 | — | — | EP | disclosed |